Mc-Val-Cit-PAB-Cl
CAS No. 1639351-92-0
Mc-Val-Cit-PAB-Cl ( —— )
Catalog No. M26985 CAS No. 1639351-92-0
Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 338 | Get Quote |
|
10MG | 502 | Get Quote |
|
25MG | 808 | Get Quote |
|
50MG | 1107 | Get Quote |
|
100MG | 1494 | Get Quote |
|
500MG | 2988 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMc-Val-Cit-PAB-Cl
-
NoteResearch use only, not for human use.
-
Brief DescriptionMc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.
-
DescriptionMc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE with IC50s of 3.3 and 0.95 nM for BJAB and WSU cell lines in cytotoxicity assay). Mc-Val-Cit-PAB-Cl is a cleavable ADC linker.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1639351-92-0
-
Formula Weight591.1
-
Molecular FormulaC28H39ClN6O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CCl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Remirez D, et al. Mechanism of protection of lobenzarit against paracetamol-induced toxicity in rat hepatocytes. Eur J Pharmacol. 1995 Dec 7;293(4):301-8.
molnova catalog
related products
-
Guaiacol
Guaiacol is a precursor to various flavorants, such as eugenol and vanillin. Its derivatives are used medicinally as an expectorant, antiseptic, and local anesthetic.
-
Octisalate
Octyl salicylate, or 2-ethylhexyl salicylate, is an organic compound used as an ingredient in sunscreens and cosmetics to absorb UVB (ultraviolet) rays from the sun.
-
Poricoic acid A
Poricoic acid A is a natural product with antitumor activity. It also enhances melatonin inhibition of AKI-to-CKD transition by regulating the Gas6/AxlNFκB/Nrf2 axis.